1,755 filings
Page 18 of 88
6-K
j0r6aintetrs9hdp9a4
31 Oct 16
Live Filing
12:00am
6-K
22vatkd9
26 Oct 16
Collaboration Features First Integration of The Weather Company data with IBM Watson Health Cloud
12:00am
6-K
5m3ot5bo lv8pr
20 Oct 16
Live Filing
12:00am
6-K
d8wigp 6i
18 Oct 16
Teva Provides Update on Godollo Manufacturing Facility
12:00am
6-K
nn675rj
17 Oct 16
Live Filing
12:00am
6-K
gz5qpu2rh5ljjc1z
17 Oct 16
Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
12:00am
6-K
39tw7e d5
12 Oct 16
Teva Announces Launch of Generic Beyaz® In the United States
12:00am
S-8
afcehdhxvby0
12 Oct 16
Registration of securities for employees
12:00am
6-K
mrx46h5w4wnqoxn
6 Oct 16
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
12:00am
6-K
xvbqcw1rg7
5 Oct 16
Teva Announces Sale of UK and Ireland Actavis Assets and Operations
12:00am
6-K
xv6nl9dwet u4k3xw8k5
3 Oct 16
Live Filing
12:00am
6-K/A
ht2051lppd93 136z
30 Sep 16
Teva Announces Launch of Generic Epzicom® Tablets
12:00am
6-K
n644 04lo30
28 Sep 16
Teva Announces Launch of Generic Epzicom® Tablets In the United States
12:00am
6-K
rff7j
22 Sep 16
SD-809 demonstrates a statistically significant improvement in Abnormal Involuntary Movement Scale score in AIM-TD study
12:00am
6-K
hfrr j3yglhtgnao
20 Sep 16
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
12:00am
6-K
x6vm 4pmykjyz
19 Sep 16
Teva Announces Results from Exploratory 52-WEEK Phase 2 Pride-hd Study of Pridopidine In Huntington Disease
12:00am
6-K
8jihd
15 Sep 16
Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin® (Daptomycin for Injection) In the United States
12:00am
6-K
qwfion50jwia8 7s
9 Sep 16
Current report (foreign)
12:00am
6-K
7bmaho4492f1w1ig a59
7 Sep 16
Teva to Present Latest Data in Multiple Sclerosis at 2016 ECTRIMS Congress in London
12:00am
6-K
msp0 oo11d02lj
6 Sep 16
Teva to Present at the Wells Fargo 2016 Healthcare Conference
12:00am